BSE · 532041
Hindustan Bio Sciences Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1 Cr with net profit ₹0 Cr — a 12.38% net margin, versus 5.47% the period before.
Shareholding
As of 2026-06-30
- Promoter12.19%
- Public87.81%
11,707 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.98× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — GSM · GSM 0. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Trading · ranked #471 of 666 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,93,459 Cr | 24.35 | 4.83 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,50,959 Cr | 381.38 | 10.26 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,60,247 Cr | 92.84 | 22.94 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹93,790 Cr | 1212.96 | 65.21 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹50,703 Cr | 56.97 | 6.83 | 11.32% | 6.61% |
| Premier Energies Limited | ₹47,038 Cr | 102.19 | 10.9 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹45,019 Cr | 109.72 | 7.44 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹40,364 Cr | 238.34 | 21.5 | 19.61% | 8.72% |
| Redington Limited | ₹22,472 Cr | 57.38 | 2.21 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,620 Cr | 210.96 | 10.36 | 14.16% | 8.36% |
| Hindustan Bio Sciences Ltd.(this company) | ₹7 Cr | — | 8.83 | -9.55% | -12.86% |
AI analysis
AI-generated · google/gemini-2.5-flashHindustan Bio Sciences Ltd. has a market capitalization of Rs 8 Cr. The company reported revenue of Rs 0.81 Cr and a negative profit margin of -12.86%. Its debt-to-equity ratio stands at 2.98. Promoter holding at the end of June 2026 was 12.1903%.
Positives
- +Annual EPS has turned positive, increasing from -0.04 in March 2023 to 0.1 in March 2025.
- +Promoter shareholding is not pledged, with promoter pledge at 0%.
Negatives
- −The company reported zero revenue in two of the last four available quarterly periods, specifically December 2024 and March 2026.
- −The profit margin is negative at -12.86%.
- −Return on equity (ROE) is negative at -9.55%, and return on capital employed (ROCE) is negative at -2.4626%.
- −The debt-to-equity ratio is high at 2.98, indicating substantial leverage.
- −Promoter holding has decreased from an unspecified higher value (previous periods not provided) to 12.1903% as of June 2026.
Financial Performance
In the financial year ending March 2025, Hindustan Bio Sciences Ltd. reported revenue of Rs 0.8133 Cr. Net profit for the same period was Rs 0.1007 Cr. Quarterly data shows revenue of Rs 0.38 Cr and net profit of Rs 0.08 Cr for the quarter ending December 2025. For the quarter ending March 2026, the company reported zero revenue and a net loss of Rs -0.12 Cr.
Profitability & Returns
The company's profit margin was -12.86%. Return on equity (ROE) was -9.55%, and return on capital employed (ROCE) was -2.4626%. In March 2025, EPS was 0.1, after reporting negative EPS in prior years, such as -0.04 in March 2023.
Balance Sheet
Hindustan Bio Sciences Ltd. has a book value of Rs 0.81. The company's debt-to-equity ratio is 2.98, indicating a significant reliance on debt for financing. Further details on assets and liabilities are not provided in the available data.
Ownership & Pledges
As of June 30, 2026, promoter holding in Hindustan Bio Sciences Ltd. was 12.1903%, while public shareholding stood at 87.8097%. There were no shares pledged by the promoters. The number of shareholders was 11707.
Regulatory & Surveillance
Hindustan Bio Sciences Ltd. is under surveillance measures. The company is marked with GSM and ESM labels, specifically 'GSM · GSM 0 · ESM · ESM 1', indicating heightened monitoring by regulatory bodies.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Hindustan Bio Sciences Ltd.share price & fundamentals